Organogenesis Holdings (ORGO) Operating Margin Growth (3y) (2020 - 2026)

Organogenesis Holdings (ORGO) Operating Margin Growth (3y) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 1,673.00
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -37.00
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -1,442.00
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 13,036.00
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 5,091.00
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 5,310.00
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -11,841.00
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 2,466.00
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -698.00
10 Organogenesis Holdings 304.80 Mn 212.70 Mn 11.46 Mn -18,133.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -18,133.00
Dec 31, 2025 507.00
Sep 30, 2025 1,222.00
Jun 30, 2025 -2,228.00
Mar 31, 2025 -3,072.00
Dec 31, 2024 -738.00
Sep 30, 2024 -888.00
Jun 30, 2024 -2,981.00
Mar 31, 2024 -1,580.00
Dec 31, 2023 -2,149.00
Sep 30, 2023 -1,520.00
Jun 30, 2023 1,157.00
Mar 31, 2023 2,072.00
Dec 31, 2022 848.00
Sep 30, 2022 526.00
Jun 30, 2022 1,326.00
Mar 31, 2022 593.00
Dec 31, 2021 2,249.00
Sep 30, 2021 3,413.00
Jun 30, 2021 5,824.00